The numbers show measurable headway.
India drove down new tuberculosis infections by 21% between 2015 and 2024, pushing treatment coverage up to 92%. The progress draws on World Health Organization data verified by the Union Ministry of Health and Family Welfare. Medical teams across the country have expanded clinical reach and tracked patient recovery closer than ever before.
Yet the danger remains massive.
India still shoulders roughly one-quarter of all tuberculosis infections on Earth—the single largest caseload carried by any country. While clinics cure millions, transmission lines continue to smoulder in densely populated neighbourhoods and economically fragile households. Medical therapy stops the bacteria, but poor living conditions invite it right back in.
To choke off hidden transmission chains, the Union Ministry of Health and Family Welfare rolled out the JOSH campaign.
JOSH—short for Joint Squad for Health—operates as a youth-driven community mobilisation push. Rather than waiting for coughing patients to walk into district hospitals, the initiative takes active surveillance directly to front doorsteps. The initial rollout spans 55 targeted districts across 11 states, focusing resources on areas where case reporting has historically lagged behind actual community spread.
| Metric / Operational Parameter | Documented Benchmark / Scope |
|---|---|
| Global TB Burden Share | ~25% (World's highest) |
| National Case Decline (2015–2024) | 21% drop in new infections |
| Official Treatment Coverage Rate | 92% across registered cases |
| JOSH Initiative Footprint | 11 States, 55 Focus Districts |
| Lead Institutional Authority | Union Ministry of Health and Family Welfare |
| Core Intervention Model | Youth-led community screening & treatment adherence |
Local youth volunteers fan out to spot early warning symptoms, coordinate diagnostic sputum testing, and keep patients locked into their multi-month antibiotic courses. Skipping doses breeds drug-resistant bacterial strains—a disaster for public hospitals and patient survival alike. JOSH squads work to ensure that patients who start regimens finish every last pill.
Public health leaders argue that prescription medicine solves only half the battlefield equation.
Dhun Davar, deputy chief executive officer and chief of programmes at the Asian Venture Philanthropy Network (AVPN), stressed that clinical tools alone cannot carry the campaign across the finish line.
A disease rooted in social and economic vulnerability can only be eliminated as underlying systems become stronger.
AVPN channels capital and technical strategy across more than 500 philanthropic organisations, foundations, and corporate funds operating in 40 international markets. The network focuses heavily on health equity, gender parity, climate resilience, and economic inclusion. According to Davar, tuberculosis thrives where social safety nets tear. Crowded dwellings, poor ventilation, and chronic malnutrition depress immune responses, transforming treatable airborne exposures into life-threatening illnesses.
Health authorities are now pairing the 55-district JOSH rollout with wider nutrition and social determinant tracking recognized by the World Health Organization. Stopping tuberculosis requires finding cases early, maintaining complete treatment adherence, and wiping out the economic vulnerabilities that feed the pathogen.